Journal of Applied Physiology Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Appl Physiol 97: 1559-1566, 2004. First published June 18, 2004; doi:10.1152/japplphysiol.00221.2004
8750-7587/04 $5.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
97/4/1559    most recent
00221.2004v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (35)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tang, K.
Right arrow Articles by Breen, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tang, K.
Right arrow Articles by Breen, E. C.

HIGHLIGHTED TOPICS
Lung Growth and Repair

Lung-targeted VEGF inactivation leads to an emphysema phenotype in mice

Kechun Tang, Harry B. Rossiter, Peter D. Wagner, and Ellen C. Breen

Division of Physiology, Department of Medicine, University of California, San Diego, La Jolla, California 92093-0623

Submitted 27 February 2004 ; accepted in final form 9 June 2004

To test the hypothesis that VEGF is important for the maintenance of alveolar structure and elastic properties in adult mice, lung-targeted ablation of the VEGF gene was accomplished through intratracheal delivery of an adeno-associated cre recombinase virus (AAV/Cre) to VEGFloxP mice, and the effects were followed for 8 wk. Control mice were similarly treated with AAV/Cre. Pulmonary VEGF levels were reduced by 86% at 5 wk postinfection but returned to normal levels by 8 wk. VEGF receptor VEGFR-2 levels were also reduced at 5 wk (by 51%) and returned to control values by 8 wk. However, alveolar septal wall destruction (increased mean linear intercept) and loss of lung elastic recoil (increased compliance) persisted for 8 wk. No decrease in alveolar cell proliferation was detected by Western blot or immunohistochemical analysis of proliferating cell nuclear antigen. Increased alveolar septal cell and bronchial epithelial cell apoptosis was detected by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling analysis at 5 wk. Total lung caspase-3 levels and enzyme activity were also increased at 5 wk. No obvious accumulation of inflammatory cells was observed at any time after tracheal instillation of AAV/Cre. Thus a transient decrease in pulmonary VEGF leads to increased alveolar and bronchial cell apoptosis, air space enlargement, and changes in lung elastic recoil (processes that are characteristic of emphysema) that persist for at least 8 wk.

vascular endothelial growth factor; caspase; cre recombinase; apoptosis


Address for reprint requests and other correspondence: E. C. Breen, Univ. of California, San Diego, Dept. of Medicine 0623A, 9500 Gilman Dr., La Jolla, CA 92093-0623 (E-mail: ebreen{at}ucsd.edu).




This article has been cited by other articles:


Home page
 J BiochemHome page
X. Wang, T. Fukuda, W. Li, C.-x. Gao, A. Kondo, A. Matsumoto, E. Miyoshi, N. Taniguchi, and J. Gu
Requirement of Fut8 for the expression of vascular endothelial growth factor receptor-2: a new mechanism for the emphysema-like changes observed in Fut8-deficient mice
J. Biochem., May 1, 2009; 145(5): 643 - 651.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
J. V. Thaikoottathil, R. J. Martin, J. Zdunek, A. Weinberger, J. G. Rino, and H. W. Chu
Cigarette smoke extract reduces VEGF in primary human airway epithelial cells
Eur. Respir. J., April 1, 2009; 33(4): 835 - 843.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Kurtagic, M. P. Jedrychowski, and M. A. Nugent
Neutrophil elastase cleaves VEGF to generate a VEGF fragment with altered activity
Am J Physiol Lung Cell Mol Physiol, March 1, 2009; 296(3): L534 - L546.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
I. A. Greaves, C. C. W. Hsia, D. M. Hyde, M. Ochs, E. R. Weibel, J. H. T. Bates, H. B. Rossiter, E. C. Breen, H. Parameswaran, A. Majumdar, et al.
Commentaries on viewpoint: use of mean airspace chord length to assess emphysema. To be or not to be-accurate.
J Appl Physiol, December 1, 2008; 105(6): 1982 - 1983.
[Full Text] [PDF]

Home page
 CirculationHome page
M. Klein, R. T. Schermuly, P. Ellinghaus, H. Milting, B. Riedl, S. Nikolova, S. S. Pullamsetti, N. Weissmann, E. Dony, R. Savai, et al.
Combined Tyrosine and Serine/Threonine Kinase Inhibition by Sorafenib Prevents Progression of Experimental Pulmonary Hypertension and Myocardial Remodeling
Circulation, November 11, 2008; 118(20): 2081 - 2090.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. J. Giordano, J. Lahdenranta, L. Zhen, U. Chukwueke, I. Petrache, R. R. Langley, I. J. Fidler, R. Pasqualini, R. M. Tuder, and W. Arap
Targeted Induction of Lung Endothelial Cell Apoptosis Causes Emphysema-like Changes in the Mouse
J. Biol. Chem., October 24, 2008; 283(43): 29447 - 29460.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Q. Lu
Transforming growth factor-{beta}1 protects against pulmonary artery endothelial cell apoptosis via ALK5
Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L123 - L133.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
B. Yucesoy, V. J. Johnson, G. E. Kissling, K. Fluharty, M. L. Kashon, J. Slaven, D. Germolec, V. Vallyathan, and M. I. Luster
Genetic susceptibility to progressive massive fibrosis in coal miners
Eur. Respir. J., June 1, 2008; 31(6): 1177 - 1182.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
A. Sharafkhaneh, N. A. Hanania, and V. Kim
Pathogenesis of Emphysema: From the Bench to the Bedside
Proceedings of the ATS, May 1, 2008; 5(4): 475 - 477.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
I Petrache, K Diab, K S Knox, H L Twigg III, R S Stephens, S Flores, and R M Tuder
HIV associated pulmonary emphysema: a review of the literature and inquiry into its mechanism
Thorax, May 1, 2008; 63(5): 463 - 469.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. D. Wagner
The biology of oxygen
Eur. Respir. J., April 1, 2008; 31(4): 887 - 890.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
S. Sakao, L. Taraseviciene-Stewart, C. D. Cool, Y. Tada, Y. Kasahara, K. Kurosu, N. Tanabe, Y. Takiguchi, K. Tatsumi, T. Kuriyama, et al.
VEGF-R blockade causes endothelial cell apoptosis, expansion of surviving CD34+ precursor cells and transdifferentiation to smooth muscle-like and neuronal-like cells
FASEB J, November 1, 2007; 21(13): 3640 - 3652.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J.-R. Tang, G. Seedorf, V. Balasubramaniam, A. Maxey, N. Markham, and S. H. Abman
Early inhaled nitric oxide treatment decreases apoptosis of endothelial cells in neonatal rat lungs after vascular endothelial growth factor inhibition
Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1271 - L1280.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
T. Yoshida and R. M. Tuder
Pathobiology of Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease
Physiol Rev, July 1, 2007; 87(3): 1047 - 1082.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
H. Fehrenbach, G. Zimmermann, E. Starke, V. A Bratu, D. Conrad, A. O Yildirim, and A. Fehrenbach
Nitrogen dioxide induces apoptosis and proliferation but not emphysema in rat lungs
Thorax, May 1, 2007; 62(5): 438 - 446.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
V. Balasubramaniam, C. F. Mervis, A. M. Maxey, N. E. Markham, and S. H. Abman
Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia
Am J Physiol Lung Cell Mol Physiol, May 1, 2007; 292(5): L1073 - L1084.
[Abstract] [Full Text] [PDF]

Home page
 ERRHome page
H. Fehrenbach
Animal models of pulmonary emphysema: a stereologist's perspective
Eur. Respir. Rev., December 1, 2006; 15(101): 136 - 147.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
R. M. Tuder, T. Yoshida, I. Fijalkowka, S. Biswal, and I. Petrache
Role of Lung Maintenance Program in the Heterogeneity of Lung Destruction in Emphysema
Proceedings of the ATS, November 1, 2006; 3(8): 673 - 679.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
L. Taraseviciene-Stewart, I. S. Douglas, P. S. Nana-Sinkam, J. D. Lee, R. M. Tuder, M. R. Nicolls, and N. F. Voelkel
Is Alveolar Destruction and Emphysema in Chronic Obstructive Pulmonary Disease an Immune Disease?
Proceedings of the ATS, November 1, 2006; 3(8): 687 - 690.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
P. M. Henson, R. W. Vandivier, and I. S. Douglas
Cell Death, Remodeling, and Repair in Chronic Obstructive Pulmonary Disease?
Proceedings of the ATS, November 1, 2006; 3(8): 713 - 717.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
R. M. Tuder, T. Yoshida, W. Arap, R. Pasqualini, and I. Petrache
State of the Art. Cellular and Molecular Mechanisms of Alveolar Destruction in Emphysema: An Evolutionary Perspective
Proceedings of the ATS, August 1, 2006; 3(6): 503 - 510.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
S. D. Shapiro
Extracellular matrix in lung disease. Proceedings of the Twenty-First Transatlantic Airway Conference.
Proceedings of the ATS, July 1, 2006; 3(5): 397 - 455.
[Full Text] [PDF]

Home page
 ThoraxHome page
A R L Medford and A B Millar
Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?
Thorax, July 1, 2006; 61(7): 621 - 626.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Morimoto, W. J. Janssen, M. B. Fessler, K. A. McPhillips, V. M. Borges, R. P. Bowler, Y.-Q. Xiao, J. A. Kench, P. M. Henson, and R. W. Vandivier
Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease.
J. Immunol., June 15, 2006; 176(12): 7657 - 7665.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. A. Marwick, C. S. Stevenson, J. Giddings, W. MacNee, K. Butler, I. Rahman, and P. A. Kirkham
Cigarette smoke disrupts VEGF165-VEGFR-2 receptor signaling complex in rat lungs and patients with COPD: morphological impact of VEGFR-2 inhibition
Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L897 - L908.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
E. R. Weibel, H. Parameswaran, A. Majumdar, S. Ito, A. M. Alencar, B. Suki, W. Mitzner, C. C. W. Hsia, H. Fehrenbach, and J. P. Butler
Morphological Quantitation of Emphysema: A Debate
J Appl Physiol, April 1, 2006; 100(4): 1419 - 1421.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. F. Voelkel, R. W. Vandivier, and R. M. Tuder
Vascular endothelial growth factor in the lung
Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L209 - L221.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
H. Parameswaran, A. Majumdar, S. Ito, A. M. Alencar, and B. Suki
Quantitative characterization of airspace enlargement in emphysema
J Appl Physiol, January 1, 2006; 100(1): 186 - 193.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. K. A. Lundblad, J. Thompson-Figueroa, T. Leclair, M. J. Sullivan, M. E. Poynter, C. G. Irvin, and J. H. T. Bates

Am. J. Respir. Crit. Care Med., December 15, 2005; 172(12): 1605b - 1606.
[Full Text] [PDF]

Home page
 CirculationHome page
K. R. Stenmark and V. Balasubramaniam
Angiogenic Therapy for Bronchopulmonary Dysplasia: Rationale and Promise
Circulation, October 18, 2005; 112(16): 2383 - 2385.
[Full Text] [PDF]

Home page
 Eur Respir JHome page
L. B. Ware, R. J. Kaner, R. G. Crystal, R. Schane, N. N. Trivedi, D. McAuley, and M. A. Matthay
VEGF levels in the alveolar compartment do not distinguish between ARDS and hydrostatic pulmonary oedema
Eur. Respir. J., July 1, 2005; 26(1): 101 - 105.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
S. A. McGrath-Morrow, C. Cho, C. Cho, L. Zhen, D. J. Hicklin, and R. M. Tuder
Vascular Endothelial Growth Factor Receptor 2 Blockade Disrupts Postnatal Lung Development
Am. J. Respir. Cell Mol. Biol., May 1, 2005; 32(5): 420 - 427.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A G Richter, E O Maughan, G D Perkins, N Nathani, and D R Thickett
VEGF levels in pulmonary fibrosis
Thorax, February 1, 2005; 60(2): 171 - 171.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.